Keeping Current
Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:36:32
- More information
Informações:
Synopsis
Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 9/22/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu
